A UBS report dinged US stocks for being “overvalued,” suggesting that better investment opportunities exist outside of US markets. Is this the next rally catalyst for Bitcoin? Key takeaways: Analysts downgraded US stocks due to high valuations, a weak dollar and policy risks despite AI-driven earnings growth. Limited S&P 500 upside may shift capital toward Bitcoin, especially if major sovereign funds announce BTC reserves. Read more
Ropharma (RPH.RO), Exchange, a pharmaceutical retail and wholesale business, ended 2025 with RON10.15 million net profit, down 4.1% from RON10.59 million in 2024, amid increased pressure on expenses.